CFO interim
MapLight Therapeutics, Inc. names Jonathan Gillis interim CFO
MapLight Therapeutics, Inc. reported in a Form 8-K filed June 18, 2026 that Jonathan Gillis was named interim interim Chief Financial Officer and interim principal financial officer, effective June 18, 2026.
In the filing's words
In connection with the separation of Mr. Setia, the board of directors of the Company appointed Jonathan Gillis, the Company’s Chief Administrative and Accounting Officer, as the Company’s interim Chief Financial Officer and interim principal financial officer, effective June 18, 2026.
Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.
| Company | MapLight Therapeutics, Inc. (MPLT) |
|---|---|
| Event | Interim |
| Incoming | Jonathan Gillis |
| Outgoing | Vishwas Setia |
| Title in the filing | interim Chief Financial Officer and interim principal financial officer |
| Effective | June 18, 2026 |
| 8-K filed | June 18, 2026 |
| Internal promotion | Not established by the source |
| SEC CIK | 0001770069 |
MapLight Therapeutics, Inc. reported this change in a Form 8-K, Item 5.02, filed June 18, 2026. The filing's own words are quoted above.
Sources
- sec.gov · SEC filing, Item 5.02 · accessed 2026-09-26
Something wrong about Jonathan Gillis? Send a correction with the primary source.